Compounds > 2-methyl-3-hydroxypyridine-5-carboxylic acid
Page last updated: 2024-11-08
2-methyl-3-hydroxypyridine-5-carboxylic acid
Description
2-methyl-3-hydroxypyridine-5-carboxylic acid: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
5-hydroxy-6-methylpyridine-3-carboxylic acid : The 5-hydroxy-6-methyl derivative of nicotinic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 439464 |
CHEBI ID | 15821 |
SCHEMBL ID | 4121189 |
MeSH ID | M0277899 |
Synonyms (17)
Synonym |
5-hydroxy-6-methylnicotinic acid |
5-hydroxy-6-methylpyridine-3-carboxylic acid |
CHEBI:15821 |
C01270 , |
3hm , |
AKOS005135731 |
3-pyridinecarboxylic acid, 5-hydroxy-6-methyl- |
7428-22-0 |
AB74651 |
SCHEMBL4121189 |
DTXSID30331415 |
2-methyl-3-hydroxy-5-carboxypyridine |
2-methyl-3-hydroxypyridine-5-carboxylic acid |
Q27098242 |
5-hydroxy-6-methylnicotinicacid |
A865925 |
CS-0331173 |
Drug Classes (2)
Class | Description |
methylpyridines | Any member of the class of pyridines that carries at least one methyl substituent. |
monohydroxypyridine | A hydroxypyridine carrying a single hydroxy substituent. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.21
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.21 (24.57) | Research Supply Index | 2.30 (2.92) | Research Growth Index | 4.51 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |